HK1094004A1 - Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains - Google Patents

Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Info

Publication number
HK1094004A1
HK1094004A1 HK06114164.5A HK06114164A HK1094004A1 HK 1094004 A1 HK1094004 A1 HK 1094004A1 HK 06114164 A HK06114164 A HK 06114164A HK 1094004 A1 HK1094004 A1 HK 1094004A1
Authority
HK
Hong Kong
Prior art keywords
lactobacillus plantarum
plantarum strains
plantarum
tannin
combination
Prior art date
Application number
HK06114164.5A
Other languages
English (en)
Inventor
Goeran Molin
Siv Ahrne
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of HK1094004A1 publication Critical patent/HK1094004A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/0102—Tannase (3.1.1.20)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
HK06114164.5A 2003-04-04 2006-12-27 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains HK1094004A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300994A SE527555C2 (sv) 2003-04-04 2003-04-04 Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US46305803P 2003-04-16 2003-04-16
PCT/SE2004/000509 WO2004087893A1 (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Publications (1)

Publication Number Publication Date
HK1094004A1 true HK1094004A1 (en) 2007-03-16

Family

ID=20290933

Family Applications (2)

Application Number Title Priority Date Filing Date
HK06114164.5A HK1094004A1 (en) 2003-04-04 2006-12-27 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
HK12103485.2A HK1162937A1 (en) 2003-04-04 2012-04-10 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12103485.2A HK1162937A1 (en) 2003-04-04 2012-04-10 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Country Status (19)

Country Link
US (3) USRE46718E1 (de)
EP (2) EP1613740B1 (de)
JP (1) JP4731469B2 (de)
KR (1) KR101122916B1 (de)
CN (2) CN1798831B (de)
AT (1) ATE546516T1 (de)
AU (1) AU2004225568B2 (de)
BR (2) BRPI0409206C1 (de)
CA (1) CA2521220C (de)
DK (1) DK1613740T3 (de)
ES (2) ES2382930T3 (de)
HK (2) HK1094004A1 (de)
PL (2) PL2163162T3 (de)
PT (1) PT1613740E (de)
RU (1) RU2356942C2 (de)
SE (1) SE527555C2 (de)
SI (1) SI1613740T1 (de)
WO (1) WO2004087893A1 (de)
ZA (1) ZA200507938B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
WO2007009187A1 (en) * 2005-07-22 2007-01-25 Tarac Technologies Pty Ltd Polyphenol and probiotic containing nutritional supplement
US20080311097A1 (en) 2005-09-28 2008-12-18 Nordisk Rebalance A/S Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
WO2007040446A1 (en) * 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
US8748121B2 (en) * 2006-10-23 2014-06-10 The Trustees Of The University Of Pennsylvania GSH adducts and uses thereof
WO2008075949A1 (en) * 2006-12-20 2008-06-26 Friesland Brands B.V. Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms
EP2136825B1 (de) * 2007-03-01 2013-11-20 Probi Ab Verwendung von lactobacillus plantarum zur erhöhung der bakterienvielfalt
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
PL2282642T3 (pl) * 2008-04-30 2013-12-31 Nestec Sa Produkty zawierające i zastosowania dekarboksylowanych kwasów fenolowych pochodzących z kwasów chlorogenowych z kawy
CN102014649B (zh) * 2008-04-30 2014-06-25 雀巢产品技术援助有限公司 用于制备包含水解绿原酸的咖啡饮料的组合物
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EP2210505A1 (de) * 2009-01-27 2010-07-28 Nestec S.A. Zusammensetzungen mit Caftarsäure und/oder Derivaten davon
EP2210504A1 (de) * 2009-01-27 2010-07-28 Nestec S.A. Zusammensetzungen mit Chicorreesäure und/oder Derivaten davon
US20110091431A1 (en) * 2009-10-09 2011-04-21 Prothera, Inc. Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
AU2010334993B2 (en) * 2009-12-22 2015-07-09 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
TWI401086B (zh) * 2010-07-20 2013-07-11 Univ China Medical 胚芽乳酸桿菌及其用途
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
JP6033290B2 (ja) 2011-06-10 2016-11-30 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ チャノキ葉から分離した新規なラクトバチルス・プランタラム
KR101295444B1 (ko) * 2011-12-22 2013-08-09 웅진식품주식회사 신규한 홍삼 발효용 미생물, 이를 이용한 홍삼 발효액 및 홍삼 발효 음료
TWI463986B (zh) 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
US11173170B2 (en) 2014-11-05 2021-11-16 Optibiotix Limited Prebiotic composition and its methods of production
ES2764210T3 (es) * 2014-11-25 2020-06-02 Dsm Ip Assets Bv Lactobacillus para usar como probiótico
RU2600445C1 (ru) * 2015-09-21 2016-10-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) Способ биоиндикации состояния двухстворчатых моллюсков в условиях техногенного загрязнения среды обитания
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
IT201700057079A1 (it) * 2017-05-25 2018-11-25 Probiotical Spa Batterioterapia a base di composizioni batteriche per il trattamento di malattie neurodegenerative
AU2018428571A1 (en) * 2018-06-18 2021-01-28 Probi Ab Lactobacillus plantarum compositions and uses thereof
WO2020096992A1 (en) * 2018-11-05 2020-05-14 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
US20220175893A1 (en) * 2019-03-05 2022-06-09 The Texas A&M University System Combinations of tannase and probiotic formulations and methods of use for improving tannin metabolism
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof
CN111500655B (zh) * 2020-03-19 2021-03-05 北京北农科技有限公司 一种五倍子单宁制备新工艺
CN112386614B (zh) * 2020-11-25 2022-11-08 天津科技大学 植物乳杆菌ma2在制备预防或改善阿尔茨海默症药物或食品方面中的应用
KR102390694B1 (ko) * 2021-07-13 2022-04-29 한국식품연구원 락티플란티바실러스 파라플란타룸 WiKim0130을 포함하는 암의 예방, 개선 또는 치료용 조성물
CN114107161B (zh) * 2021-11-15 2023-06-20 泸州老窖股份有限公司 一种混合驯化菌株降解石榴皮生产鞣花酸的方法
CN113980858B (zh) * 2021-11-18 2023-05-02 上海植酵盛生物科技有限公司 一株产高活性单宁酶的植物乳杆菌yl399及其在制备党参发酵饲料中的应用
CN117384879B (zh) * 2023-01-13 2024-04-30 中国农业科学院茶叶研究所 一种适应茶汁体系的耐酸单宁酶制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453763A1 (fr) 1979-04-14 1980-11-07 Teves Gmbh Alfred Regulateur de force de freinage a deux circuits, comportant un piston d'arret actionnable hydrauliquement
JPS5785326A (en) 1980-11-14 1982-05-28 Asahi Glass Co Ltd Stabilization of flon
JPS6425726A (en) * 1987-04-24 1989-01-27 Yuutoku Yakuhin Kogyo Kk Agent for eliminating active oxygen free radical
SE463796B (sv) * 1988-03-09 1991-01-28 Carl Erik Albertsson Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP3459837B2 (ja) 1992-05-12 2003-10-27 太陽化学株式会社 生菌粉末
JP4127863B2 (ja) 1993-03-04 2008-07-30 太陽化学株式会社 腸内環境改善組成物
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
SE9501719D0 (sv) * 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
EP1117414A1 (de) 1998-10-01 2001-07-25 Probi Ab Reduktion von faktoren des oxidativen stresses
FR2789580A1 (fr) * 1999-02-12 2000-08-18 Oreal Compositions cosmetiques antisolaires a base d'un melange synergique de filtres et utilisations
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
SE0004124D0 (sv) 2000-11-10 2000-11-10 Probi Ab New use
KR100549193B1 (ko) * 2002-10-23 2006-02-02 (주)바이오뉴트리젠 인삼 및 폴리페놀계 물질 또는 바이오플라보노이드계 물질을 포함하는 식물의 분말 또는 추출물을 포함하는 항비만용 식품

Also Published As

Publication number Publication date
ATE546516T1 (de) 2012-03-15
US7507572B2 (en) 2009-03-24
WO2004087893A9 (en) 2006-03-30
CN102210717A (zh) 2011-10-12
RU2005134223A (ru) 2006-03-10
US20060257384A1 (en) 2006-11-16
AU2004225568B2 (en) 2008-02-14
BRPI0409206A (pt) 2006-03-28
ZA200507938B (en) 2007-03-28
EP2163162A1 (de) 2010-03-17
CN102210717B (zh) 2013-02-06
WO2004087893A1 (en) 2004-10-14
USRE44400E1 (en) 2013-07-30
PL1613740T3 (pl) 2012-07-31
ES2382930T3 (es) 2012-06-14
CN1798831A (zh) 2006-07-05
SI1613740T1 (sl) 2012-09-28
ES2751101T3 (es) 2020-03-30
RU2356942C2 (ru) 2009-05-27
PT1613740E (pt) 2012-05-28
PL2163162T3 (pl) 2020-02-28
AU2004225568A1 (en) 2004-10-14
DK1613740T3 (da) 2012-05-21
EP1613740A1 (de) 2006-01-11
KR101122916B1 (ko) 2012-06-13
SE0300994L (sv) 2004-10-05
EP1613740B1 (de) 2012-02-22
BRPI0409206B8 (pt) 2019-01-22
BRPI0409206B1 (pt) 2018-11-06
CA2521220A1 (en) 2004-10-14
BR122018068574B1 (pt) 2021-10-26
HK1162937A1 (en) 2012-09-07
SE527555C2 (sv) 2006-04-11
USRE46718E1 (en) 2018-02-20
SE0300994D0 (sv) 2003-04-04
EP2163162B1 (de) 2019-08-07
JP2006521817A (ja) 2006-09-28
JP4731469B2 (ja) 2011-07-27
BRPI0409206C1 (pt) 2021-05-25
CN1798831B (zh) 2011-05-18
KR20060005356A (ko) 2006-01-17
CA2521220C (en) 2014-05-27

Similar Documents

Publication Publication Date Title
HK1162937A1 (en) Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
IN2004KO00092A (de)
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EP1143985A3 (de) Verwendung von lactobacillus salivarius
EP1918373A4 (de) Agens und nahrungsmittel gegen obesität
MXPA04008182A (es) Composicion fotoprotectora para la piel, oralmente adminstrable.
MX2007006866A (es) Composiciones que tiene una alta eficacia antiviral y antibacterial.
WO2005055934A3 (en) Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
DK1624762T3 (da) Probiotisk præparat med mindst to mælkesyrebakteriestammer som er i stand til kolonisere mavetarmkanalen, i kombination med at de besidder overlevelsesegenskab, tarmbindende egenskab, en infektionsbeskyttelsesegenskab og en fiberfermenterende egenskab
BRPI0514969A (pt) casco de aço para um rolo de sucção e um método de produção de um produto de aço
WO2006128089A3 (en) Compositions and methods for treating tissue
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
EP2298860A3 (de) Verfahren zur Herstellung von Rohbakterienstämmen und deren Verwendungen
WO2003045405A3 (fr) Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
GB0203307D0 (en) Method
WO2003070873A3 (de) Kultivierungsverfahren für mikroorganismen und bioreaktor
MX2009006887A (es) Agentes para promover la produccion de iga.
WO2004002240A3 (en) Use of hydrocolloids as prebiotic food ingredients and method of producing the same
AU2002361172A1 (en) Yeast-based curative and care product and method for making same
ATE395414T1 (de) Glukose dehydrogenase und ihre herstellung
AU6430200A (en) Cyanobacterial strain of the genus nostoc, cultures, biomasses, extracts, bioactive molecules obtained therefrom and use thereof

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240330